Pharmaceutical PV DIV - FSB
Ended Awarded
- Contract number
- SPE2DU26FEMMR
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,707
Award facts
- Contract value 100% obligated
- $1,706.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,706.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on November 10, 2025. This delivery order was issued without a set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables to Department of Defense healthcare facilities, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical devices. The company has demonstrated substantial federal contracting activity through numerous delivery orders from the Defense Logistics Agency's Medical Supply Chain division, with previous awards ranging from under $100 to exceeding $115,000.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency, designated SPE2DR under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The parent contract, awarded on November 13, 2025, carries a ceiling value of $499.999 billion and an ultimate completion date of December 31, 2036, structured with a 30-month base period and three 30-month option periods. The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors supplying pharmaceutical products to support recurring medical supply needs of military healthcare facilities worldwide, positioning DMS Pharmaceutical Group as a critical component of the Department of Defense's global pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DU26FEMMR?
SPE2DU26FEMMR was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 10, 2025.
How much is contract SPE2DU26FEMMR worth?
The government has obligated $1,707 on SPE2DU26FEMMR.
Is contract SPE2DU26FEMMR an order under another contract?
Yes. SPE2DU26FEMMR is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMMR competed?
The extent of competition for SPE2DU26FEMMR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award